FEMALE HEALTH

BE:FMW Germany Other
Market Cap
$30.48K
€29.69K EUR
Market Cap Rank
#43203 Global
#6896 in Germany
Share Price
€3.16
Change (1 day)
+900.00%
52-Week Range
€0.31 - €3.16
All Time High
€23.42
About

FEMALE HEALTH operates in Diversified Metals & Mining.

FEMALE HEALTH (FMW) - Net Assets

Latest net assets as of June 2024: €37.62 Million EUR

Based on the latest financial reports, FEMALE HEALTH (FMW) has net assets worth €37.62 Million EUR as of June 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€64.63 Million) and total liabilities (€27.01 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €37.62 Million
% of Total Assets 58.21%
Annual Growth Rate -7.49%
5-Year Change -39.14%
10-Year Change N/A
Growth Volatility 153.07

FEMALE HEALTH - Net Assets Trend (2016–2023)

This chart illustrates how FEMALE HEALTH's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for FEMALE HEALTH (2016–2023)

The table below shows the annual net assets of FEMALE HEALTH from 2016 to 2023.

Year Net Assets Change
2023-09-30 €19.68 Million -76.23%
2022-09-30 €82.80 Million -45.63%
2021-09-30 €152.29 Million +405.77%
2020-09-30 €30.11 Million -6.87%
2019-09-30 €32.33 Million +9.67%
2018-09-30 €29.48 Million -39.15%
2017-09-30 €48.45 Million +42.79%
2016-09-30 €33.93 Million --

Equity Component Analysis

This analysis shows how different components contribute to FEMALE HEALTH's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 22911699400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (September 2023)

Component Amount Percentage
Other Components €276.45 Million 1404.84%
Total Equity €19.68 Million 100.00%

FEMALE HEALTH Competitors by Market Cap

The table below lists competitors of FEMALE HEALTH ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in FEMALE HEALTH's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from 82,797,317 to 19,678,161, a change of -63,119,156 (-76.2%).
  • Net loss of 93,152,692 reduced equity.
  • New share issuances of 6,009,366 increased equity.
  • Other factors increased equity by 24,024,170.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income €-93.15 Million -473.38%
Share Issuances €6.01 Million +30.54%
Other Changes €24.02 Million +122.09%
Total Change €- -76.23%

Book Value vs Market Value Analysis

This analysis compares FEMALE HEALTH's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 14.75x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 3.47x to 14.75x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-09-30 €0.91 €3.16 x
2018-09-30 €0.53 €3.16 x
2019-09-30 €0.50 €3.16 x
2020-09-30 €0.43 €3.16 x
2021-09-30 €1.90 €3.16 x
2022-09-30 €1.03 €3.16 x
2023-09-30 €0.21 €3.16 x

Capital Efficiency Dashboard

This dashboard shows how efficiently FEMALE HEALTH utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -473.38%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -571.60%
  • • Asset Turnover: 0.33x
  • • Equity Multiplier: 2.54x
  • Recent ROE (-473.38%) is below the historical average (-95.46%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 1.02% 1.56% 0.57x 1.14x €-3.05 Million
2017 -13.65% -48.42% 0.25x 1.14x €-11.46 Million
2018 -81.20% -150.89% 0.33x 1.64x €-26.89 Million
2019 -37.17% -37.79% 0.59x 1.66x €-15.25 Million
2020 -63.01% -44.55% 0.83x 1.71x €-21.98 Million
2021 4.86% 12.07% 0.34x 1.17x €-7.84 Million
2022 -101.18% -212.88% 0.29x 1.63x €-92.06 Million
2023 -473.38% -571.60% 0.33x 2.54x €-95.12 Million

Industry Comparison

This section compares FEMALE HEALTH's net assets metrics with peer companies in the Other industry.

Industry Context

  • Industry: Other
  • Average net assets among peers: $114,212,818,724
  • Average return on equity (ROE) among peers: -9.08%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
FEMALE HEALTH (FMW) €37.62 Million 1.02% 0.72x $29.41K
HORIBA (01H) $204.49 Billion 10.42% 0.82x $989.01K
Tokyu Corporation (01T) $779.37 Billion 3.34% 2.35x $99.73K
GUANGZHOU AUTO -H- (02G) $122.28 Billion 6.59% 0.55x $4.05K
MOSAIC (02M) $10.60 Billion 4.43% 0.90x $280.83K
MOSAIC (02M.SG) (02M) $9.56 Billion 10.46% 0.82x $247.21K
CHINA JO-JO DRGSTRS (04CN.SG) (04CN) $16.67 Million -126.83% 4.46x $1.55 Million
KRAKATAU STEEL -B- (07K) $552.59 Million 3.52% 4.72x $166.99
CN MODERN DAIRY (07M) $7.12 Billion -10.42% 1.50x $1.68K
TOURMALINE OIL (08T) $7.22 Billion 4.81% 0.41x $381.02K
ASIA CASSAVA RESOUR (0ACS) $913.15 Million 2.86% 1.55x $325.03